Enrikas Vainorius, M.D., has garnered more than 10 years of research experience from the pharmaceutical industry and academia, including Pharmaceutical Product Development Inc. (PPD), Duke University, University of Maryland at Baltimore, University of Aarhus (Denmark, EU) and Kaunas Medical University (Lithuania, EU). He employs expertise in numerous areas of clinical trials and research, including project management, clinical medicine, clinical trials, research design, research execution and clinical trial monitoring.
During his tenure at PPD Inc., he was actively involved in direct study and clinical project team activities across multiple therapeutic project areas of clinical trials. Before transferring to the pharmaceutical industry, Vainorius completed postdoctoral fellowships in several academic institutions. At Duke University he was actively involved in a bench-to-bedside project that allowed for evaluation of progenitor cells and their impact on cardiac disease. Titled "Role of Human Circulating Endothelial Progenitor Cells in Cardiac Risk Assessment," the program was designed to develop safe, reliable clinical diagnostic processes for future trials. Prior to this project he designed and executed a project evaluation of the Role of Circulating Endothelial Progenitor Cells in Restenosis Development due to Angioplasty Procedure. His work resulted in the creation of a cellular-based novel therapy designed to prevent the restenosis development in arteries after balloon angioplasty. During his biomedical research career Vainorius received several awards and fellowships for the postdoctoral research at University Of Maryland and Aarhus University.
Currently, Vainorius serves as the Program Manager of the Clinical Program, and is providing management support for the NIEHS Environmental Polymorphisms Registry (EPR). Vainorius is also responsible for delegating and managing data evaluation/statistical evaluations and graphical presentations, as directed by the NIEHS PI and study biostatistician. In addition to management of clinically-related projects, Vainorius has the overall responsibility for the processing, storage, management, and distribution of biospecimens held at ILS.
